Pharmaceutical News

RSS

New era in cancer prevention

Nearly two decades ago, researchers at the National Cancer Institute (NCI) and other institutions began searching for the underlying causes of cervical cancer.

9 Jun 2006

FDA approves Gardasil as a treatment for cervical cancer

Merck & Co. has announced that the U.S. Food and Drug Administration (FDA) approved Gardasil as a treatment for cervical cancer, vulvar and vaginal pre-cancers caused by HPV types 16 and 18 and to prevent low-grade and pre-cancerous lesions and genital warts caused by HPV types 6, 11, 16 and 18.

9 Jun 2006

Markey Cancer Center receives approval to test cancer drug DB-67

Tom Burke died of colon cancer only a few years ago, but not before he helped create a new drug to fight cancer.

8 Jun 2006

NHS could save 2 billion pounds by switching to generic cholesterol lowering drugs

The NHS in England could save over £2bn in the next five years if doctors simply switched patients to cheaper generic cholesterol lowering drugs (statins), say two senior doctors in this week's British Medical Journal.

8 Jun 2006

FDA approval of Gardasil to prevent cervical cancer

The Food and Drug Administration (FDA) has announced the approval of Gardasil, the first vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to human papillomavirus (HPV) types 6, 11, 16 and 18.

8 Jun 2006

Reovirus could be used to treat many forms of advanced cancer

An experimental drug called Reolysin may give hope to patients suffering from advanced cancers, according to research presented at this year's meeting of the American Society of Clinical Oncology (ASCO).

8 Jun 2006

Europe gives approval for children to get Prozac

The European Medicines Agency (EMEA) has given it's approval for the antidepressant Prozac to be made available to children.

8 Jun 2006

Glivec the best news yet for cancer victims

In what is great news for those suffering from chronic myeloid leukaemia (CML), the drug Glivec looks like being one of the biggest breakthroughs in cancer therapy for a years.

7 Jun 2006

MS sufferers relieved as drug Tysabri goes back on the market

The Food and Drug Administration in the U.S. has given it's approval for the multiple sclerosis drug Tysabri to be put back on the market.

6 Jun 2006

FDA approves resumed marketing of Tysabri

The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.

5 Jun 2006

HHS awards BioShield contract heptavalent botulism antitoxin

HHS has awarded a contract to the Cangene Corporation in the amount of $362,641,105 for 200,000 doses of Heptavalent Botulism Antitoxin.

5 Jun 2006

New EU rules mean medicines will be developed just for children

In a rather worrying revelation it appears that fifty percent of the medicines currently used to treat children have only been tested on adults.

4 Jun 2006

New vaccine reduces the risk of shingles

A new vaccine which reduces the risk of shingles (herpes zoster) for use in people 60 years of age and older has won approval from the U.S. Food and Drug Administration.

29 May 2006

Thalomid gets FDA approval to treat multiple myeloma

Thalomid (thalidomide) has been given a new lease of life following the United States Food and Drug Administration (FDA) approval for the drug to be used in combination with the steroid dexamethasone for the treatment of newly diagnosed multiple myeloma.

29 May 2006

Herceptin plus hormonal therapy holds breast cancer in check

Drug giant Roche believes it has proof that its cancer drug Herceptin when used in combination with hormonal therapy increases the time that some breast-cancer patients live without the cancer progressing.

29 May 2006

Misuse of ADHD drugs sends thousands each year to seek emergency hospital treatment

Scientists at the U.S. Centers for Disease Control and Prevention (CDC) have estimated that problems with the drugs used to treat attention deficit disorders force as many as 3,100 people to seek emergency hospital treatment each year.

25 May 2006

EU ruling on breast drug Herceptin will end 'post code lottery' in Britain

The European Union has approved the use of the breast cancer drug Herceptin for use in patients with an early stage of the aggressive HER2-positive type of breast cancer.

24 May 2006

Arthritis drug wins approval for use in children with Crohn's disease

The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.

21 May 2006

Plan B - Lancet has a go at the FDA

A well known international medical journal has called on the acting FDA Commissioner Andrew von Eschenbach to adopt an independent stance and follow the best judgment of it's expert staff and scientific advisers, even when that means incurring the wrath of patients' groups, industry, Congress, and even the White House.

21 May 2006